CervoMed Announces New Data at the 2026 AAN Annual Meeting that Demonstrated Neflamapimod Increased Basal Forebrain Volume and Functional Connectivity in Dementia with Lewy Bodies
Go back to CervoMed Announces New Data at the 2026 AAN Annual Meeting that Demonstrated Neflamapimod Increased Basal Forebrain Volume and Functional Connectivity in Dementia with Lewy Bodies| (NASDAQ: CRVO) | Delayed: 3.86 -0.27 (6.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.13 | 52 Week High | $ | |||
| Open | $3.97 | 52 Week Low | $ | |||
| Day High | $4.11 | P/E | N/A | |||
| Day Low | $3.79 | EPS | $ | |||
| Volume | 666,379 | |||||
